Colonial Trust Advisors Grows Holdings in Stryker Co. (SYK)

Colonial Trust Advisors grew its position in Stryker Co. (NYSE:SYK) by 40.9% during the fourth quarter, Holdings Channel reports. The fund owned 33,883 shares of the medical technology company’s stock after acquiring an additional 9,836 shares during the quarter. Colonial Trust Advisors’ holdings in Stryker were worth $5,246,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Geode Capital Management LLC increased its stake in Stryker by 2.8% in the 4th quarter. Geode Capital Management LLC now owns 3,159,538 shares of the medical technology company’s stock worth $488,110,000 after acquiring an additional 85,614 shares during the last quarter. Jensen Investment Management Inc. increased its stake in Stryker by 0.3% in the 4th quarter. Jensen Investment Management Inc. now owns 2,478,958 shares of the medical technology company’s stock worth $383,842,000 after acquiring an additional 6,482 shares during the last quarter. Lazard Asset Management LLC increased its stake in Stryker by 15.5% in the 4th quarter. Lazard Asset Management LLC now owns 2,208,379 shares of the medical technology company’s stock worth $341,945,000 after acquiring an additional 296,550 shares during the last quarter. Legal & General Group Plc increased its stake in Stryker by 2.8% in the 3rd quarter. Legal & General Group Plc now owns 1,805,572 shares of the medical technology company’s stock worth $256,393,000 after acquiring an additional 49,143 shares during the last quarter. Finally, Wells Fargo & Company MN increased its stake in Stryker by 4.8% in the 3rd quarter. Wells Fargo & Company MN now owns 1,742,959 shares of the medical technology company’s stock worth $247,536,000 after acquiring an additional 79,551 shares during the last quarter. 75.68% of the stock is currently owned by institutional investors and hedge funds.

How to Become a New Pot Stock Millionaire

In other Stryker news, VP William E. Berry, Jr. sold 1,306 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $164.42, for a total value of $214,732.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Howard E. Cox, Jr. sold 7,400 shares of the company’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $164.09, for a total value of $1,214,266.00. The disclosure for this sale can be found here. Insiders sold a total of 98,730 shares of company stock valued at $16,360,442 over the last quarter. Company insiders own 7.40% of the company’s stock.

A number of research firms have issued reports on SYK. Needham & Company LLC reaffirmed a “hold” rating on shares of Stryker in a research note on Wednesday, January 17th. Robert W. Baird upgraded Stryker from a “neutral” rating to an “outperform” rating in a report on Friday, November 24th. ValuEngine cut Stryker from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Royal Bank of Canada reiterated a “buy” rating and issued a $175.00 target price on shares of Stryker in a report on Tuesday, January 9th. Finally, Morgan Stanley lifted their target price on Stryker from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Monday, February 26th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $164.76.

Stryker stock opened at $164.73 on Thursday. Stryker Co. has a 1-year low of $129.82 and a 1-year high of $170.00. The company has a current ratio of 2.29, a quick ratio of 1.59 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $62,201.81, a price-to-earnings ratio of 61.47, a P/E/G ratio of 2.39 and a beta of 0.70.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.95 by $0.01. Stryker had a return on equity of 24.56% and a net margin of 8.20%. The company had revenue of $3.47 billion during the quarter, compared to analysts’ expectations of $3.42 billion. During the same quarter in the previous year, the business earned $1.78 EPS. Stryker’s revenue was up 9.9% compared to the same quarter last year. equities analysts expect that Stryker Co. will post 7.12 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, April 30th. Shareholders of record on Thursday, March 29th will be issued a $0.47 dividend. This represents a $1.88 annualized dividend and a dividend yield of 1.14%. The ex-dividend date of this dividend is Wednesday, March 28th. Stryker’s dividend payout ratio is 70.15%.

WARNING: “Colonial Trust Advisors Grows Holdings in Stryker Co. (SYK)” was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.com-unik.info/2018/03/22/colonial-trust-advisors-grows-holdings-in-stryker-co-syk.html.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit